Cargando…
Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS
Polycystic ovary syndrome (PCOS) is an endocrine/metabolic disorder associated with insulin resistance (IR) and obesity. Endometria from women with PCOS present failures in insulin action, glucose uptake and signaling of insulin-sensitizing molecules, such as adiponectin, with consequences for repro...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999908/ https://www.ncbi.nlm.nih.gov/pubmed/35409282 http://dx.doi.org/10.3390/ijms23073922 |
_version_ | 1784685303809703936 |
---|---|
author | Oróstica, Maria Lorena Astorga, Isis Plaza-Parrochia, Francisca Poblete, Cristian Carvajal, Rodrigo García, Víctor Romero, Carmen Vega, Margarita |
author_facet | Oróstica, Maria Lorena Astorga, Isis Plaza-Parrochia, Francisca Poblete, Cristian Carvajal, Rodrigo García, Víctor Romero, Carmen Vega, Margarita |
author_sort | Oróstica, Maria Lorena |
collection | PubMed |
description | Polycystic ovary syndrome (PCOS) is an endocrine/metabolic disorder associated with insulin resistance (IR) and obesity. Endometria from women with PCOS present failures in insulin action, glucose uptake and signaling of insulin-sensitizing molecules, such as adiponectin, with consequences for reproduction. Metformin (MTF) treatment improves insulin signaling in endometrial tissues, but its mechanism is not fully understood. This study addresses the MTF effect, as well as adiponectin agonist action, on levels of molecules associated with insulin and adiponectin signaling pathways in endometrial tissue and cells, as assessed by immunohistochemistry and immunocytochemistry, respectively. Endometrial tissues were obtained from women and divided into five groups: Normal Weight (control); Obesity + IR; Obesity + IR + PCOS; Obesity + IR + MTF; Obesity + IR + PCOS + MTF. Endometrial cells stimulated with TNFα (as obesity-marker) were also used to partially emulate an obesity environment. The results showed low levels of insulin/adiponectin signaling in the endometria from women with obesity, IR and PCOS compared with the control group. MTF re-established these levels, independently of PCOS. TNFα-associated molecules were elevated in pathologic endometria, whereas MTF diminished these levels. The low levels of insulin/adiponectin molecules in endometrial cells treated with TNFα were reverted by MTF, similar to what was observed in the case of the adiponectin agonist. Therefore, independently of PCOS, MTF can re-establish levels of molecules involved in insulin/adiponectin signaling in endometrial cells, suggesting an improvement in insulin action and reproductive failures observed in endometria from women with obesity/PCOS. |
format | Online Article Text |
id | pubmed-8999908 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89999082022-04-12 Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS Oróstica, Maria Lorena Astorga, Isis Plaza-Parrochia, Francisca Poblete, Cristian Carvajal, Rodrigo García, Víctor Romero, Carmen Vega, Margarita Int J Mol Sci Article Polycystic ovary syndrome (PCOS) is an endocrine/metabolic disorder associated with insulin resistance (IR) and obesity. Endometria from women with PCOS present failures in insulin action, glucose uptake and signaling of insulin-sensitizing molecules, such as adiponectin, with consequences for reproduction. Metformin (MTF) treatment improves insulin signaling in endometrial tissues, but its mechanism is not fully understood. This study addresses the MTF effect, as well as adiponectin agonist action, on levels of molecules associated with insulin and adiponectin signaling pathways in endometrial tissue and cells, as assessed by immunohistochemistry and immunocytochemistry, respectively. Endometrial tissues were obtained from women and divided into five groups: Normal Weight (control); Obesity + IR; Obesity + IR + PCOS; Obesity + IR + MTF; Obesity + IR + PCOS + MTF. Endometrial cells stimulated with TNFα (as obesity-marker) were also used to partially emulate an obesity environment. The results showed low levels of insulin/adiponectin signaling in the endometria from women with obesity, IR and PCOS compared with the control group. MTF re-established these levels, independently of PCOS. TNFα-associated molecules were elevated in pathologic endometria, whereas MTF diminished these levels. The low levels of insulin/adiponectin molecules in endometrial cells treated with TNFα were reverted by MTF, similar to what was observed in the case of the adiponectin agonist. Therefore, independently of PCOS, MTF can re-establish levels of molecules involved in insulin/adiponectin signaling in endometrial cells, suggesting an improvement in insulin action and reproductive failures observed in endometria from women with obesity/PCOS. MDPI 2022-04-01 /pmc/articles/PMC8999908/ /pubmed/35409282 http://dx.doi.org/10.3390/ijms23073922 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Oróstica, Maria Lorena Astorga, Isis Plaza-Parrochia, Francisca Poblete, Cristian Carvajal, Rodrigo García, Víctor Romero, Carmen Vega, Margarita Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS |
title | Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS |
title_full | Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS |
title_fullStr | Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS |
title_full_unstemmed | Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS |
title_short | Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS |
title_sort | metformin treatment regulates the expression of molecules involved in adiponectin and insulin signaling pathways in endometria from women with obesity-associated insulin resistance and pcos |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999908/ https://www.ncbi.nlm.nih.gov/pubmed/35409282 http://dx.doi.org/10.3390/ijms23073922 |
work_keys_str_mv | AT orosticamarialorena metformintreatmentregulatestheexpressionofmoleculesinvolvedinadiponectinandinsulinsignalingpathwaysinendometriafromwomenwithobesityassociatedinsulinresistanceandpcos AT astorgaisis metformintreatmentregulatestheexpressionofmoleculesinvolvedinadiponectinandinsulinsignalingpathwaysinendometriafromwomenwithobesityassociatedinsulinresistanceandpcos AT plazaparrochiafrancisca metformintreatmentregulatestheexpressionofmoleculesinvolvedinadiponectinandinsulinsignalingpathwaysinendometriafromwomenwithobesityassociatedinsulinresistanceandpcos AT pobletecristian metformintreatmentregulatestheexpressionofmoleculesinvolvedinadiponectinandinsulinsignalingpathwaysinendometriafromwomenwithobesityassociatedinsulinresistanceandpcos AT carvajalrodrigo metformintreatmentregulatestheexpressionofmoleculesinvolvedinadiponectinandinsulinsignalingpathwaysinendometriafromwomenwithobesityassociatedinsulinresistanceandpcos AT garciavictor metformintreatmentregulatestheexpressionofmoleculesinvolvedinadiponectinandinsulinsignalingpathwaysinendometriafromwomenwithobesityassociatedinsulinresistanceandpcos AT romerocarmen metformintreatmentregulatestheexpressionofmoleculesinvolvedinadiponectinandinsulinsignalingpathwaysinendometriafromwomenwithobesityassociatedinsulinresistanceandpcos AT vegamargarita metformintreatmentregulatestheexpressionofmoleculesinvolvedinadiponectinandinsulinsignalingpathwaysinendometriafromwomenwithobesityassociatedinsulinresistanceandpcos |